- The European Respiratory Society (ERS) convened experts to review the evidence and develop major consensus recommendations for managing bronchopulmonary dysplasia (BPD).
- Also called chronic lung disease of prematurity, this chronic respiratory disease largely affects children born very preterm.
- Guidelines are aimed at infants/children discharged from hospital, or children >36 weeks postmenstrual age.
Why this matters
- There are no existing recommendations for this pediatric population.
- Literature review and evaluation of evidence quality by Grading of Recommendations, Assessment, Development and Evaluation.
- Funding: ERS.
- Monitor patients with ionizing radiation for lung imaging only in certain subgroups of patients (e.g., severe BPD, severe respiratory symptoms, etc).
- Monitor lung function of all patients, usually with spirometry.
- Give personalized advice about whether children should attend daycare.
- Bronchodilator treatment may be used only for subgroups, such as severe BPD, severe respiratory or asthma-like symptoms, recurrent hospital admission, exercise intolerance, etc.
- No treatment with inhaled or systemic corticosteroids, unless regular use is warranted by clinician discretion.
- Natural weaning of diuretics as infants gain weight; use of diuretics in other infants/children by clinician discretion.
- Supplemental oxygen with a saturation target of 90%-95%.
- Quality of evidence very low for all but 1 recommendation: the quality of evidence is low for recommendation against corticosteroids.